143 related articles for article (PubMed ID: 28529561)
1. Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.
Li X; Yan J; Fan R; Luo B; Zhang Q; Lin Y; Zhou S; Luo G; Xie X; Xiao S
Oncol Lett; 2017 May; 13(5):3080-3086. PubMed ID: 28529561
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
3. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
[TBL] [Abstract][Full Text] [Related]
4. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
Tammela J; Uenaka A; Ono T; Noguchi Y; Jungbluth AA; Mhawech-Fauceglia P; Qian F; Schneider S; Sharma S; Driscoll D; Lele S; Old LJ; Nakayama E; Odunsi K
Int J Oncol; 2006 Oct; 29(4):903-10. PubMed ID: 16964386
[TBL] [Abstract][Full Text] [Related]
5. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
[TBL] [Abstract][Full Text] [Related]
6. Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.
Fan R; Huang W; Luo B; Zhang QM; Xiao SW; Xie XX
Eur J Gynaecol Oncol; 2015; 36(3):298-303. PubMed ID: 26189257
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.
Cen YH; Guo WW; Luo B; Lin YD; Zhang QM; Zhou SF; Luo GR; Xiao SW; Xie XX
Cell Biol Int; 2012 Oct; 36(10):917-22. PubMed ID: 22651134
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues.
Fu J; Yingying Ge ; Qingmei Zhang ; Lin Y; Liu C; Nong W; Luo X; Xiao S; Xie X; Luo B
J Healthc Eng; 2022; 2022():7052830. PubMed ID: 35463688
[TBL] [Abstract][Full Text] [Related]
10. Identification of an HLA-A24-restricted OY-TES-1 epitope recognized by cytotoxic T-cells.
Okumura H; Noguchi Y; Uenaka A; Aji T; Ono T; Nakagawa K; Aoe M; Shimizu N; Nakayama E
Microbiol Immunol; 2005; 49(11):1009-16. PubMed ID: 16301813
[TBL] [Abstract][Full Text] [Related]
11. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.
Hu Q; Fu J; Luo B; Huang M; Guo W; Lin Y; Xie X; Xiao S
Oncol Rep; 2015 Apr; 33(4):1965-75. PubMed ID: 25673160
[TBL] [Abstract][Full Text] [Related]
12. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
13. Identification of glioma-specific RFX4-E and -F isoforms and humoral immune response in patients.
Matsushita H; Uenaka A; Ono T; Hasegawa K; Sato S; Koizumi F; Nakagawa K; Toda M; Shingo T; Ichikawa T; Noguchi Y; Tamiya T; Furuta T; Kawase T; Date I; Nakayama E
Cancer Sci; 2005 Nov; 96(11):801-9. PubMed ID: 16271074
[TBL] [Abstract][Full Text] [Related]
14. Identification of a human glioma antigen, SOX6, recognized by patients' sera.
Ueda R; Iizuka Y; Yoshida K; Kawase T; Kawakami Y; Toda M
Oncogene; 2004 Feb; 23(7):1420-7. PubMed ID: 14691456
[TBL] [Abstract][Full Text] [Related]
15. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535
[TBL] [Abstract][Full Text] [Related]
17. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer testis genes in human brain tumors.
Sahin U; Koslowski M; Türeci O; Eberle T; Zwick C; Romeike B; Moringlane JR; Schwechheimer K; Feiden W; Pfreundschuh M
Clin Cancer Res; 2000 Oct; 6(10):3916-22. PubMed ID: 11051238
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel human cancer/testis antigen, KM-HN-1, recognized by cellular and humoral immune responses.
Monji M; Nakatsura T; Senju S; Yoshitake Y; Sawatsubashi M; Shinohara M; Kageshita T; Ono T; Inokuchi A; Nishimura Y
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6047-57. PubMed ID: 15447989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]